Serological responses to Anthrax Vaccine Precipitated (AVP) increase with time interval between booster doses-Reference-Cited by-同舟云学术

Serological responses to Anthrax Vaccine Precipitated (AVP) increase with time interval between booster doses

Published:2022-10 Issue:42 Volume:40 Page:6163-6178
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Dyson E. Hugh,Simpson Andrew J.H.,Gwyther Robert J.,Cuthbertson Hannah,Patient Dawn H.,Matheson Mary,Gregg Anya,Hepburn Matthew J.,Hallis Bassam,Williamson E. Diane

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference53 articles.

1. Anthrax as a biological weapon: updated recommendations for management;Inglesby;JAMA,2002

2. Anthrax vaccination in a military population before the war in Iraq: side effects and informed choice;Murphy;Vaccine,2007

3. A longitudinal study of UK military personnel offered anthrax vaccination: informed choice, symptom reporting, uptake and pre-vaccination health;Murphy;Vaccine,2012

4. Safety of anthrax vaccine: an expanded review and evaluation of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS);Sever;Pharmacoepidemiol Drug Saf,2004

5. Friedlander AM, Grabenstein JD, Brachman PS. Anthrax vaccines. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. 6th ed. Philadelphia: Elsevier Saunders; 2013. p. 127–40 [Chap 10]. ISBN-13: 9781455737987.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anthrax Vaccines in the 21st Century;Vaccines;2024-02-03

2. Human Exposure to Naturally Occurring Bacillus anthracis in the Kars Region of Eastern Türkiye;Microorganisms;2024-01-14

3. Humoral and Cellular Immune Responses of People Living With Human Immunodeficiency Virus After 3 Doses of Messenger RNA BNT162b2 Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine: A Prospective Cohort Study;Open Forum Infectious Diseases;2023-07-10

4. Recombinant full-length Bacillus Anthracis protective antigen and its 63 kDa form elicits protective response in formulation with addavax;Frontiers in Immunology;2023-01-12